CREBBP knockdown suppressed proliferation and promoted chemo-sensitivity via PERK-mediated unfolded protein response in ovarian cancer
Haoyang Hu, Sheng Yin, Ruyue Ma, Rujun Chen, Shuqing Li, Yaping Chen, Fei He, Lina Yang · Journal of Cancer · 2021
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2021
Abstract
CREBBP, in short CBP, has been reported to be involved in tumorigenesis in various cancers, but its role in ovarian cancer remains largely unexplored.In our study, survival analysis of CBP in patients with ovarian cancer was conducted using the Kaplan-Meier Plotter database, then we utilized specific shRNA targeting CREBBP to block the expression of CBP, and detected its effect on cell proliferation and chemo-sensitivity in ovarian cancer cells.The results showed that high expression of CBP was correlated with poor prognosis in ovarian cancer patients.CREBBP knockdown in ovarian cancer cells significantly inhibited tumor proliferation both in vitro and in vivo.Moreover, CREBBP knockdown promoted chemo-sensitivity in ovarian cancer cells.Mechanism research further demonstrated that CREBBP knockdown attenuated unfolded protein response (UPR), which was mediated by PERK/ATF4/STC2 signaling pathway.Our research linked CBP and UPR in ovarian cancer and may provide new strategies for the clinical treatment of ovarian cancer.
Open the resolved locator · 10.7150/jca.56135
Metadata licence: OpenAlex metadata (CC0)